DNA methylation landscapes in DIPG reveal methylome variability that can be modified pharmacologically
Ashley R Tetens(Johns Hopkins University), Michael A. Koldobskiy(Johns Hopkins University), Rakel Tryggvadóttir(Johns Hopkins University), Charles G. Eberhart(Johns Hopkins University), Antje Arnold(Johns Hopkins University), Allison Martin(Albert Einstein College of Medicine), Eric H. Raabe(Johns Hopkins University), Orlandi Novak(Johns Hopkins University), Adam Resnick(Children's Hospital of Philadelphia), Jordyn Craig-Schwartz(Johns Hopkins University), Athanasia Liapodimitri(Johns Hopkins University), Adrian Idrizi(Johns Hopkins University), Kayleigh Lunsford(Johns Hopkins University), Michael I. Barbato(Center for Drug Evaluation and Research)
Cited by 6
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k